FMC Corporation (FMC)
40.85
1.53 (3.89%)
At close: Apr 24, 2025, 3:59 PM
40.70
-0.38%
After-hours: Apr 24, 2025, 06:54 PM EDT
FMC Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fungicides Revenue | 84.8M | 74.5M | 70.4M | 88.8M | 55.5M | 72.3M | 101M | 136.6M | 75.3M | 63.3M | 108.7M | 77.1M | 63.4M | 94.5M | 90.5M | 71M | 59.4M | 61.8M | 83.3M | 81.4M | 61.3M | 58.2M | 70.5M |
| Fungicides Revenue Growth | +13.83% | +5.82% | -20.72% | +60.00% | -23.24% | -28.42% | -26.06% | +81.41% | +18.96% | -41.77% | +40.99% | +21.61% | -32.91% | +4.42% | +27.46% | +19.53% | -3.88% | -25.81% | +2.33% | +32.79% | +5.33% | -17.45% | n/a |
| Herbicides Revenue | 275.6M | 336.6M | 294.9M | 342.1M | 268M | 225.5M | 442.8M | 543.3M | 323.6M | 380.3M | 404.4M | 420.5M | 262.3M | 330.8M | 361.7M | 264.7M | 214.7M | 340.6M | 367.2M | 318.8M | 199M | 349.4M | 361.6M |
| Herbicides Revenue Growth | -18.12% | +14.14% | -13.80% | +27.65% | +18.85% | -49.07% | -18.50% | +67.89% | -14.91% | -5.96% | -3.83% | +60.31% | -20.71% | -8.54% | +36.65% | +23.29% | -36.96% | -7.24% | +15.18% | +60.20% | -43.05% | -3.37% | n/a |
| Insecticides Revenue | 647.9M | 569.1M | 501.3M | 651.4M | 582.4M | 658.9M | 746.7M | 810.5M | 872.3M | 897.1M | 766.7M | 798.9M | 792.3M | 741.8M | 687M | 689.7M | 746.8M | 679.9M | 720.4M | 710.2M | 649.7M | 710.3M | 703.4M |
| Insecticides Revenue Growth | +13.85% | +13.52% | -23.04% | +11.85% | -11.61% | -11.76% | -7.87% | -7.08% | -2.76% | +17.01% | -4.03% | +0.83% | +6.81% | +7.98% | -0.39% | -7.65% | +9.84% | -5.62% | +1.44% | +9.31% | -8.53% | +0.98% | n/a |
| Plant Health Revenue | 47.3M | 43.5M | 44.8M | 48.6M | 42.6M | 43.4M | 52.3M | 64.8M | 53.2M | 62.7M | 53.4M | 61M | 53.5M | 52.1M | 50.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Plant Health Revenue Growth | +8.74% | -2.90% | -7.82% | +14.08% | -1.84% | -17.02% | -19.29% | +21.80% | -15.15% | +17.42% | -12.46% | +14.02% | +2.69% | +3.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 981.7M | 1.24B | 1.25B | 1.11B | 1.05B | 1.3B | 718.5M | 798.5M | 759.7M | 775.9M | 679.2M | 651.5M | 577.7M |
| Asia Pacific Revenue Growth | -20.74% | -1.28% | +13.35% | +5.89% | -19.60% | +80.93% | -10.02% | +5.11% | -2.09% | +14.24% | +4.25% | +12.77% | n/a |
| Brazil Revenue | 1.02B | 1.62B | 1.22B | 1.08B | 1.09B | 913.7M | 598.5M | 509.4M | 662.5M | 958.8M | 1.04B | 846.6M | 695.2M |
| Brazil Revenue Growth | -37.25% | +32.40% | +13.01% | -0.98% | +19.74% | +52.66% | +17.49% | -23.11% | -30.90% | -8.08% | +23.21% | +21.78% | n/a |
| Emea Revenue | 899.2M | 1.04B | 1.04B | 1.05B | 1B | 1.04B | 583.4M | 783.4M | 623.9M | 559M | 1.29B | 1.3B | 1.19B |
| Emea Revenue Growth | -13.51% | -0.03% | -0.60% | +4.44% | -3.72% | +78.35% | -25.53% | +25.56% | +11.61% | -56.50% | -1.06% | +9.26% | n/a |
| Latin America Revenue | 1.4B | 2.09B | 1.63B | 1.46B | 1.44B | 1.21B | 868.6M | 821.4M | 981.8M | 1.33B | 1.24B | 1.22B | 1.11B |
| Latin America Revenue Growth | -32.90% | +27.84% | +12.15% | +1.03% | +18.94% | +39.55% | +5.75% | -16.34% | -26.43% | +7.21% | +2.22% | +9.75% | n/a |
| North America Revenue | 1.2B | 1.44B | 1.12B | 1.03B | 1.12B | 1.18B | 708.1M | 879.1M | 911.1M | 1.37B | n/a | n/a | n/a |
| North America Revenue Growth | -16.09% | +28.52% | +8.20% | -7.90% | -4.60% | +65.97% | -19.45% | -3.51% | -33.41% | n/a | n/a | n/a | n/a |
| United States Revenue | 978.1M | 1.29B | 1.02B | 941.2M | 1.04B | 1.07B | 655.2M | 837.7M | 853M | 1.31B | n/a | n/a | n/a |
| United States Revenue Growth | -24.11% | +26.59% | +8.17% | -9.86% | -2.80% | +63.95% | -21.79% | -1.79% | -35.07% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 159.2M | 164.9M | 164M | 171.5M | 171.3M | 205.6M | 185.9M | 212.5M | 179.4M | 194.8M | 188.5M | 195.1M | 183.5M | 161M | 174.5M | 181.6M | 187.7M | 171M | 189.4M | 223.8M | 188.3M | 196.9M | 183.9M | 202.6M | 207.6M | 211.4M | 200.4M | 231.6M | 150.9M | 126.4M | 109.7M | 156.1M | 117.8M | 129.1M | 126.5M | 147M | 137M | 156M | 297.9M |
| Selling, General, and Administrative Revenue Growth | -3.46% | +0.55% | -4.37% | +0.12% | -16.68% | +10.60% | -12.52% | +18.45% | -7.91% | +3.34% | -3.38% | +6.32% | +13.98% | -7.74% | -3.91% | -3.25% | +9.77% | -9.71% | -15.37% | +18.85% | -4.37% | +7.07% | -9.23% | -2.41% | -1.80% | +5.49% | -13.47% | +53.48% | +19.38% | +15.22% | -29.72% | +32.51% | -8.75% | +2.06% | -13.95% | +7.30% | -12.18% | -47.63% | n/a |
| Research and Development Revenue | 69M | 75.9M | 60.9M | 81.8M | 80.9M | 87.7M | 78.4M | 84.4M | 78.5M | 79.5M | 71.8M | 85.3M | 79.5M | 65.9M | 74M | 84.6M | 71.7M | 64.3M | 67.3M | 76.4M | 77.4M | 73.1M | 71.2M | 76.8M | 70.9M | 77M | 65.9M | 51.1M | 30.2M | 32M | 28.2M | 38.2M | 32.2M | 35.1M | 36M | 40.9M | 37.2M | 39M | 26.6M |
| Research and Development Revenue Growth | -9.09% | +24.63% | -25.55% | +1.11% | -7.75% | +11.86% | -7.11% | +7.52% | -1.26% | +10.72% | -15.83% | +7.30% | +20.64% | -10.95% | -12.53% | +17.99% | +11.51% | -4.46% | -11.91% | -1.29% | +5.88% | +2.67% | -7.29% | +8.32% | -7.92% | +16.84% | +28.96% | +69.21% | -5.62% | +13.48% | -26.18% | +18.63% | -8.26% | -2.50% | -11.98% | +9.95% | -4.62% | +46.62% | n/a |